High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome (Q39920459)

15 September 2017

title

High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome (English)

1 reference

15 September 2017

1 reference

1 reference

N Grinshtein

1

1 reference

15 September 2017

M Ventresca

2

1 reference

15 September 2017

R Margl

3

1 reference

15 September 2017

D Bernard

4

1 reference

15 September 2017

T-C Yang

5

1 reference

15 September 2017

J B Millar

6

1 reference

15 September 2017

J Hummel

7

1 reference

15 September 2017

F Beermann

8

1 reference

15 September 2017

Y Wan

9

1 reference

15 September 2017

J L Bramson

10

1 reference

15 September 2017

language of work or name

1 reference

7 November 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

16

1 reference

15 September 2017

issue

4

1 reference

15 September 2017

page(s)

338-350

1 reference

Coupling and uncoupling of tumor immunity and autoimmunity

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

A modified tyrosinase-related protein 2 epitope generates high-affinity tumor-specific T cells but does not mediate therapeutic efficacy in an intradermal tumor model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Chemotherapy enhances CD8(+) T cell-mediated antitumor immunity induced by vaccination with vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Therapeutic vaccination against murine lymphoma by intratumoral injection of naive dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Anti-tumor T cell response and protective immunity in mice that received sublethal irradiation and immune reconstitution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Tumor lysate-pulsed dendritic cells can elicit an effective antitumor immune response during early lymphoid recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Cutting edge: naive T cells masquerading as memory cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Elevated Frequencies of Self-reactive CD8+ T Cells following Immunization with a Xenoantigen Are Due to the Presence of a Heteroclitic CD4+ T-Cell Helper Epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Vaccination-induced autoimmune vitiligo is a consequence of secondary trauma to the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

CTL-dependent and -independent antitumor immunity is determined by the tumor not the vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Identification of tyrosinase-related protein 2 as a tumor rejection antigen for the B16 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Recombinant Adenovirus Vaccines Can Successfully Elicit CD8+ T Cell Immunity under Conditions of Extreme Leukopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Therapeutic effectiveness of recombinant cancer vaccines is associated with a prevalent T-cell receptor alpha usage by melanoma-specific CD8+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

The response of autologous T cells to a human melanoma is dominated by mutated neoantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Tumor rejection by disturbing tumor stroma cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Immune suppression in cancer: effects on immune cells, mechanisms and future therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Immunosuppressive networks in the tumour environment and their therapeutic relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Melanocytes and pigmentation are affected in dopachrome tautomerase knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

The CD8+ T cell population elicited by recombinant adenovirus displays a novel partially exhausted phenotype associated with prolonged antigen presentation that nonetheless provides long-term immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

On the role of CD4+ T cells in the CD8+ T-cell response elicited by recombinant adenovirus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Progression of armed CTL from draining lymph node to spleen shortly after localized infection with herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Detailed analysis of the CD8+ T-cell response following adenovirus vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

T cell homeostatic proliferation elicits effective antitumor autoimmunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

New generation vaccine induces effective melanoma-specific CD8+ T cells in the circulation but not in the tumor site

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.89

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.89

1 reference

Dimensions Publication ID

15 September 2017

1018434959

0 references

1 reference